Dabigatran Level Before Reversal Can Predict Hemostatic Effectiveness of Idarucizumab in a Real-World Setting

Background: Idarucizumab has been included in guidelines for the management of bleeding or surgical procedure in dabigatran-treated patients without need for biological monitoring. The aim of the study was to assess the prognostic value of dabigatran plasma level before reversal to test the hemostat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Med (Lausanne)
Main Authors: Gendron, Nicolas, Chocron, Richard, Billoir, Paul, Brunier, Julien, Camoin-Jau, Laurence, Tuffigo, Marie, Faille, Dorothée, Teissandier, Dorian, Gay, Juliette, de Raucourt, Emmanuelle, Suner, Ludovic, Bonnet, Corentin, Martin, Anne-Céline, Lasne, Dominique, Ladhari, Chayma, Lebreton, Aurélien, Bertoletti, Laurent, Ajzenberg, Nadine, Gaussem, Pascale, Morange, Pierre-Emmanuel, Le Cam Duchez, Véronique, Viallon, Alain, Roy, Pierre-Marie, Lillo-le Louët, Agnès, Smadja, David M.
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2020
Teme:
Medicine
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7772865/
https://ncbi.nlm.nih.gov/pubmed/33392223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.599626
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki